The Zhitong Finance App learned that Novo Nordisk (NVO.US) rose more than 6% to $42.64 on Wednesday. According to the news, Novo Nordisk's financial report on November 4 shows that adjusted sales for the third quarter reached DKK 79.2 billion, higher than market expectations of 73.55 billion kroner; adjusted profit before interest and tax was 31.72 billion kroner, which also greatly exceeded expectations of 28.71 billion kroner.

The Zhitong Finance App learned that Novo Nordisk (NVO.US) rose more than 6% to $42.64 on Wednesday. According to the news, Novo Nordisk's financial report on November 4 shows that adjusted sales for the third quarter reached DKK 79.2 billion, higher than market expectations of 73.55 billion kroner; adjusted profit before interest and tax was 31.72 billion kroner, which also greatly exceeded expectations of 28.71 billion kroner.